{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:56:12Z","timestamp":1791294972882,"version":"4.1.0"},"reference-count":57,"publisher":"American Chemical Society (ACS)","issue":"39","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001298","name":"Presbyterian Health Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007926","name":"University of Oklahoma","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022885","name":"Oklahoma Center for Adult Stem Cell Research","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100022885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2048130"],"award-info":[{"award-number":["2048130"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R35GM150758"],"award-info":[{"award-number":["5R35GM150758"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM135009"],"award-info":[{"award-number":["P20GM135009"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA225520"],"award-info":[{"award-number":["P30CA225520"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM154635"],"award-info":[{"award-number":["P30GM154635"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this study, we developed a library of mRNA lipid nanoparticles (LNPs) containing clinically used ionizable lipids. We surface-modified these nanoparticles with heparosan polysaccharides and systematically compared their performance with conventional poly(ethylene glycol) (PEG)-modified formulations. Our heparosan (HEP)-coated LNPs increased mRNA expression in dendritic and macrophage cell lines by up to \u223c10-fold. Mechanistic studies using live-cell imaging and intracellular nanoparticle trafficking analysis revealed that HEP-modified LNPs exhibited reduced colocalization with late endosomal (Rab7+) and lysosomal (LAMP1+) compartments. These findings are consistent with enhanced endosomal escape of HEP-modified formulations. Repeated subcutaneous administrations of HEP-modified firefly luciferase mRNA-LNPs demonstrated sustained expression and distinct response dynamics in mice. We further observed significantly enhanced humoral anti-spike protein immune responses in mice after subcutaneous administration of HEP-modified LNPs containing SARS-CoV-2 spike S-2P mRNA. Histopathological evaluation and spleen immune cell profiling showed no observable toxicity or adverse effects. Overall, these results demonstrate the effects of HEP surface modification on mRNA LNP expression, intracellular trafficking, and in vivo activity, and support HEP-based surface engineering as a PEG-free approach for nucleic acid delivery and potential future applications in nanomedicine.<\/jats:p>","DOI":"10.1021\/acsnano.6c11865","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:02:23Z","timestamp":1790236943000},"page":"26664-26686","source":"Crossref","is-referenced-by-count":0,"title":["Lipid Nanoparticle\nSurface Engineering with Heparosan\nPolysaccharides Enhances mRNA Efficacy via Reduced Endosomal Retention"],"prefix":"10.1021","volume":"20","author":[{"given":"Yuxin","family":"He","sequence":"first","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-8225","authenticated-orcid":true,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6667-4053","authenticated-orcid":true,"given":"Abigael P.","family":"Williams","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha I.","family":"Valerio","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Sun","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bowman","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha D.","family":"Ricketts","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Campus , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah","family":"Hammond","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Sison","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jezan","family":"Alexandre","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Niastor","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei R.","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixy E.","family":"Green","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Campus , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar-Ming","family":"Fung","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Campus , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]},{"name":"University of Oklahoma , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"DeAngelis","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Campus , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-6221","authenticated-orcid":true,"given":"Stefan","family":"Wilhelm","sequence":"additional","affiliation":[{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]},{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]},{"name":"University of Oklahoma , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]},{"name":"University of Oklahoma , , , ,","place":["Oklahoma City, Oklahoma, United States, 73104"]},{"name":"University of Oklahoma , , , ,","place":["Norman, Oklahoma, United States, 73019"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026100609080303900_cit1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid Nanoparticles\nfor MRNA Delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"2026100609080303900_cit2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of\nNanoparticle Cellular\nUptake, Intracellular Trafficking, and Kinetics in Nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Delivery Rev."},{"issue":"22","key":"2026100609080303900_cit3","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1007\/s00216-020-02783-6","article-title":"Assessing\nNanoparticle\nColloidal Stability with Single-Particle Inductively Coupled Plasma\nMass Spectrometry (SP-ICP-MS)","volume":"412","author":"Donahue","year":"2020","journal-title":"Anal. Bioanal.\nChem."},{"issue":"5","key":"2026100609080303900_cit4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG Immunity: Emergence, Characteristics,\nand\nUnaddressed Questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev.:\nNanomed. Nanobiotechnol."},{"key":"2026100609080303900_cit5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jconrel.2018.08.022","article-title":"Anti-Polyethylene Glycol\nAntibodies Alter the Protein Corona Deposited on Nanoparticles and\nthe Physiological Pathways Regulating Their Fate in Vivo","volume":"287","author":"Grenier","year":"2018","journal-title":"J. Controlled Release"},{"key":"2026100609080303900_cit6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG Antibodies\nCompromise the\nIntegrity of PEGylated Lipid-Based Nanoparticles via Complement","volume":"341","author":"Senti","year":"2022","journal-title":"J. Controlled Release"},{"key":"2026100609080303900_cit7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1039\/d3nh00198a","article-title":"Anti-PEG Antibodies\nEnriched in the Protein Corona of PEGylated Nanocarriers Impact the\nCell Uptake","volume":"8","author":"Deuker","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"2026100609080303900_cit8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-pharmtox-032320","article-title":"Nanoparticle Toxicology","volume":"61","author":"Yang","year":"2021","journal-title":"Annu.\nRev. Pharmacol. Toxicol."},{"issue":"5","key":"2026100609080303900_cit9","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1021\/acs.nanolett.2c00349","article-title":"Nanoparticle Surface Engineering with Heparosan Polysaccharide\nReduces Serum Protein Adsorption and Enhances Cellular Uptake","volume":"22","author":"Yang","year":"2022","journal-title":"Nano Lett."},{"issue":"17","key":"2026100609080303900_cit10","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1021\/acs.nanolett.2c02226","article-title":"Controlling Nanoparticle\nUptake in Innate Immune Cells with Heparosan Polysaccharides","volume":"22","author":"Yang","year":"2022","journal-title":"Nano Lett."},{"issue":"9","key":"2026100609080303900_cit11","doi-asserted-by":"publisher","first-page":"8376","DOI":"10.1021\/acsnano.2c12808","article-title":"Quantifying Intracellular Nanoparticle\nDistributions with Three-Dimensional Super-Resolution Microscopy","volume":"17","author":"Sheth","year":"2023","journal-title":"ACS Nano"},{"issue":"18","key":"2026100609080303900_cit12","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1007\/s00216-023-04540-x","article-title":"Quantification of Monodisperse\nand Biocompatible Gold Nanoparticles by Single-Particle ICP-MS","volume":"415","author":"Frickenstein","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"issue":"19","key":"2026100609080303900_cit13","doi-asserted-by":"publisher","first-page":"23250","DOI":"10.1021\/acsanm.4c04838","article-title":"The Predictive\nSynthesis of Monodisperse and Biocompatible Gold Nanoparticles","volume":"7","author":"Frickenstein","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"issue":"20","key":"2026100609080303900_cit14","doi-asserted-by":"publisher","first-page":"28536","DOI":"10.1021\/acsami.6c05213","article-title":"Lipid Nanoparticle Surface Engineering with Heparosan\nPolysaccharides for Safe and Effective MRNA Delivery In Vitro and\nIn Vivo","volume":"18","author":"He","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"2026100609080303900_cit15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/glycob\/cwx070","article-title":"Heparosan-Coated\nLiposomes for Drug Delivery","volume":"27","author":"Lane","year":"2017","journal-title":"Glycobiology"},{"key":"2026100609080303900_cit16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1517\/17425247.2015.978282","article-title":"Heparosan,\na Promising \u201cnaturally Good\u201d Polymeric Conjugating Vehicle\nfor Delivery of Injectable Therapeutics","volume":"12","author":"Deangelis","year":"2015","journal-title":"Expert\nOpin. Drug Delivery"},{"issue":"7","key":"2026100609080303900_cit17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-Based Analysis\nof Lipid Nanoparticle-Mediated SiRNA Delivery, Intracellular Trafficking\nand Endosomal Escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"2026100609080303900_cit18","doi-asserted-by":"publisher","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The MRNA-LNP\nPlatform\u2019s Lipid\nNanoparticle Component Used in Preclinical Vaccine Studies Is Highly\nInflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"2026100609080303900_cit19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/17425247.2024.2375400","article-title":"Understanding\nNanoparticle-Liver Interactions in Nanomedicine","volume":"21","author":"He","year":"2024","journal-title":"Expert Opin. Drug Delivery"},{"key":"2026100609080303900_cit20","doi-asserted-by":"publisher","first-page":"2308446","DOI":"10.1002\/adfm.202308446","article-title":"Exploring and Analyzing\nthe Systemic Delivery\nBarriers for Nanoparticles","volume":"34","author":"Wang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"2026100609080303900_cit21","doi-asserted-by":"publisher","first-page":"17718","DOI":"10.1021\/acs.analchem.5c08235","article-title":"Label-Free\nand High-Throughput Quantification of Nanoparticle\u2013Cell Interactions\nat the Single-Cell Level with Flow Cytometry","volume":"98","author":"Mohammadnejad","year":"2026","journal-title":"Anal. Chem."},{"issue":"11","key":"2026100609080303900_cit22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal Escape: A Bottleneck for\nLNP-Mediated Therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"issue":"1","key":"2026100609080303900_cit23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran,\nan RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"2026100609080303900_cit24","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the\nMRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"2026100609080303900_cit25","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy\nof the BNT162b2MRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl.\nJ. Med."},{"issue":"3","key":"2026100609080303900_cit26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1021\/acs.nanolett.3c04171","article-title":"Toward the Scalable, Rapid, Reproducible,\nand Cost-Effective Synthesis of Personalized Nanomedicines at the\nPoint of Care","volume":"24","author":"Young","year":"2024","journal-title":"Nano Lett."},{"key":"2026100609080303900_cit27","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41563-025-02240-8","article-title":"Poly (Carboxybetaine)\nLipids Enhance\nMRNA Therapeutics Efficacy and Reduce Their Immunogenicity","volume":"24","author":"Luozhong","year":"2025","journal-title":"Nat. Mater."},{"issue":"3","key":"2026100609080303900_cit28","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1021\/acsanm.9b02541","article-title":"Exploring\nMaleimide-Based Nanoparticle Surface Engineering to Control Cellular\nInteractions","volume":"3","author":"Lee","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"2026100609080303900_cit29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1021\/acs.biochem.0c00860","article-title":"Disulfide Bridging Strategies in\nViral and Nonviral Platforms for Nucleic Acid Delivery","volume":"60","author":"Dutta","year":"2021","journal-title":"Biochemistry"},{"key":"2026100609080303900_cit30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the Intricate\nIn-Vivo Journey of Lipid Nanoparticles\nTailored for the Targeted Delivery of RNA Therapeutics: A Quality-by-Design\nApproach","volume":"22","author":"Haghighi","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"2026100609080303900_cit31","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/emboj.2011.286","article-title":"Endosome Maturation","volume":"30","author":"Huotari","year":"2011","journal-title":"EMBO J."},{"issue":"5","key":"2026100609080303900_cit32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.cell.2005.06.043","article-title":"Rab Conversion as a\nMechanism of Progression from Early to Late Endosomes","volume":"122","author":"Rink","year":"2005","journal-title":"Cell"},{"issue":"5","key":"2026100609080303900_cit33","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of Nanoparticle\nDelivery\nto Tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"2026100609080303900_cit34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","article-title":"Measurement\nof Co-localization of\nObjects in Dual-colour Confocal Images","volume":"169","author":"Manders","year":"1993","journal-title":"J. Microsc."},{"issue":"8","key":"2026100609080303900_cit35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing Lipid-Formulated SiRNA Release from Endosomes\nand Target Gene Knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"2026100609080303900_cit36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief Update\non Endocytosis of Nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv. Drug Delivery\nRev."},{"key":"2026100609080303900_cit37","doi-asserted-by":"publisher","first-page":"40293","DOI":"10.1021\/acsnano.5c11721","article-title":"Endosomal\nEscape of Lipid Nanoparticles: A Perspective on the Literature Data","volume":"19","author":"Pei","year":"2025","journal-title":"ACS Nano"},{"issue":"12","key":"2026100609080303900_cit38","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1039\/D0BM01947J","article-title":"Illuminating Endosomal\nEscape of Polymorphic Lipid Nanoparticles That Boost MRNA Delivery","volume":"9","author":"Herrera","year":"2021","journal-title":"Biomater. Sci."},{"issue":"1","key":"2026100609080303900_cit39","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1038\/s41467-025-60959-z","article-title":"Cellular and Biophysical\nBarriers\nto Lipid Nanoparticle Mediated Delivery of RNA to the Cytosol","volume":"16","author":"Johansson","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"2026100609080303900_cit40","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein Corona Formed\non Lipid Nanoparticles\nCompromises Delivery Efficiency of MRNA Cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"2026100609080303900_cit41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jnt5030007","article-title":"Anti-Poly(Ethylene Glycol) (PEG) Antibodies: From Where\nAre We Coming and Where Are We Going","volume":"5","author":"Simberg","year":"2024","journal-title":"J. Nanotheranostics"},{"key":"2026100609080303900_cit42","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/pharmaceutics17081074","article-title":"Anti-PEG Antibodies and Their Biological\nImpact on PEGylated Drugs: Challenges and Strategies for Optimization","volume":"17","author":"Fu","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026100609080303900_cit43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression\nKinetics of Nucleoside-Modified MRNA Delivered in Lipid Nanoparticles\nto Mice by Various Routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Controlled Release"},{"key":"2026100609080303900_cit44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"MRNA Vaccines-a New\nEra in Vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"2","key":"2026100609080303900_cit45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4049\/jimmunol.2300500","article-title":"Modulating Antigen\nAvailability in Lymphoid Organs\nto Shape the Humoral Immune Response to Vaccines","volume":"212","author":"Aung","year":"2024","journal-title":"J. Immunol."},{"issue":"8","key":"2026100609080303900_cit46","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG Antibodies Boosted in Humans\nby SARS-CoV-2 Lipid Nanoparticle MRNA Vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"2026100609080303900_cit47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG Antibodies:\nProperties, Formation, Testing and Role in Adverse Immune Reactions\nto PEGylated Nano-Biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug\nDelivery Rev."},{"key":"2026100609080303900_cit48","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct Antibody and\nMemory B Cell Responses\nin SARS-CoV-2 Nai\u0308ve and Recovered Individuals after MRNA Vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci. Immunol."},{"issue":"6","key":"2026100609080303900_cit49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.cell.2022.01.027","article-title":"Germinal Center Responses\nto SARS-CoV-2 MRNA Vaccines in Healthy and Immunocompromised Individuals","volume":"185","author":"Lederer","year":"2022","journal-title":"Cell"},{"key":"2026100609080303900_cit50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41587-026-03099-z","article-title":"mRNA Vaccine Immunity Is Enhanced by Hepatocyte Detargeting\nand Not Dependent on Dendritic Cell Expression","author":"Marks","year":"2026","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"2026100609080303900_cit51","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient Targeting and Activation of Antigen-Presenting\nCells In Vivo after Modified MRNA Vaccine Administration in Rhesus\nMacaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"2026100609080303900_cit52","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1038\/s41467-024-51411-9","article-title":"Innate Immune Responses\nagainst MRNA Vaccine Promote\nCellular Immunity through IFN-\u03b2 at the Injection Site","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"issue":"7870","key":"2026100609080303900_cit53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 MRNA\nVaccines Induce Persistent\nHuman Germinal Centre Responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"2026100609080303900_cit54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle\nUptake: The Phagocyte Problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"issue":"14","key":"2026100609080303900_cit55","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/17576180.2024.2360361","article-title":"Biodistribution\nof Lipid Nanoparticle, EGFP MRNA and Translated Protein Following\nSubcutaneous Administration in Mouse","volume":"16","author":"Sandelius","year":"2024","journal-title":"Bioanalysis"},{"issue":"6","key":"2026100609080303900_cit56","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-Modified\nMRNA Vaccines Induce Potent T Follicular Helper and Germinal Center\nB Cell Responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"issue":"535","key":"2026100609080303900_cit57","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav8075","article-title":"Design of Anti-Inflammatory Heparan Sulfate to Protect\nagainst Acetaminophen-Induced Acute Liver Failure","volume":"12","author":"Arnold","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.6c11865","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/39\/26664\/68633100\/acsnano.6c11865.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/39\/26664\/68633100\/acsnano.6c11865.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:12:26Z","timestamp":1791292346000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/20\/39\/26664\/5437351\/Lipid-Nanoparticle-Surface-Engineering-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":57,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2026,9,24]]},"published-print":{"date-parts":[[2026,10,6]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.6c11865","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}